{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:14:17Z","timestamp":1791317657608,"version":"4.3.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bj.2023.100685","type":"journal-article","created":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T03:05:42Z","timestamp":1702177542000},"page":"100685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Aptamer-functionalized liposomes for drug delivery"],"prefix":"10.1016","volume":"47","author":[{"given":"Ka-Ying","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Sau","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5918-9336","authenticated-orcid":false,"given":"Juewen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bj.2023.100685_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat Rev Mater"},{"issue":"4","key":"10.1016\/j.bj.2023.100685_bib2","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bj.2023.100685_bib3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.bj.2023.100685_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.omtm.2023.06.005","article-title":"Lipid nanoparticle mrna systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues","volume":"30","author":"Chander","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"10.1016\/j.bj.2023.100685_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/D0NH00605J","article-title":"Targeted liposomal drug delivery: a nanoscience and biophysical perspective","volume":"6","author":"Liu","year":"2021","journal-title":"Nanoscale Horizons"},{"issue":"19","key":"10.1016\/j.bj.2023.100685_bib6","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem Rev"},{"key":"10.1016\/j.bj.2023.100685_bib7","first-page":"401","article-title":"Functionalized liposomes for targeted breast cancer drug delivery","volume":"24","author":"Nel","year":"2023","journal-title":"Bioact Mater"},{"issue":"3","key":"10.1016\/j.bj.2023.100685_bib8","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3390\/ijms24032643","article-title":"Liposomes for tumor targeted therapy: a review","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.bj.2023.100685_bib9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/1061186X.2012.734311","article-title":"Design and development of liposomes for colon targeted drug delivery","volume":"21","author":"Gupta","year":"2013","journal-title":"J Drug Target"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1120672118769776","article-title":"Novel drug delivery systems for ocular therapy: with special reference to liposomal ocular delivery","volume":"29","author":"Bhattacharjee","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.bj.2023.100685_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2017.11.042","article-title":"Folate-targeted liposomal nitrooxy-doxorubicin: an effective tool against P-glycoprotein-positive and folate receptor-positive tumors","volume":"270","author":"Gazzano","year":"2018","journal-title":"J Contr Release"},{"key":"10.1016\/j.bj.2023.100685_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2021.03.006","article-title":"Bioevaluation of glucose-modified liposomes as a potential drug delivery system for cancer treatment using 177-Lu radiotracking","volume":"33","author":"Cvjetinovi\u0107","year":"2021","journal-title":"J Contr Release"},{"issue":"23","key":"10.1016\/j.bj.2023.100685_bib13","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.3390\/molecules25235672","article-title":"Recent progress in bioconjugation strategies for liposome-mediated drug delivery","volume":"25","author":"Almeida","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib14","doi-asserted-by":"crossref","DOI":"10.1063\/5.0029860","article-title":"Peptide functionalized liposomes for receptor targeted cancer therapy","volume":"5","author":"Aronson","year":"2021","journal-title":"APL Bioeng"},{"issue":"7","key":"10.1016\/j.bj.2023.100685_bib15","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.3390\/ijms24076615","article-title":"Liposomes in cancer therapy: How did we start and where are we now","volume":"24","author":"Fulton","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40580-019-0193-2","article-title":"Current trends and challenges in cancer management and therapy using designer nanomaterials","volume":"6","author":"Navya","year":"2019","journal-title":"Nano Convergence"},{"issue":"4","key":"10.1016\/j.bj.2023.100685_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/molecules23040907","article-title":"Liposomal drug delivery systems and anticancer drugs","volume":"23","author":"Olusanya","year":"2018","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bj.2023.100685_bib18","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.3390\/ijms21124522","article-title":"Chemical modification of aptamers for increased binding affinity in diagnostic applications: current status and future prospects","volume":"21","author":"Elskens","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.bj.2023.100685_bib19","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsami.0c05750","article-title":"Recent progress in aptamer discoveries and modifications for therapeutic applications","volume":"13","author":"Ni","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"10.1016\/j.bj.2023.100685_bib20","article-title":"Selection of DNA aptamers for sensing uric acid in simulated tears","volume":"2","author":"Liu","year":"2022","journal-title":"Anal Sens"},{"issue":"20","key":"10.1016\/j.bj.2023.100685_bib21","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3390\/molecules24203781","article-title":"G-quadruplex-forming aptamers-characteristics, applications, and perspectives","volume":"24","author":"Roxo","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bj.2023.100685_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/cancers10030080","article-title":"Aptamer therapeutics in cancer: current and future","volume":"10","author":"Morita","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.bj.2023.100685_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.omtn.2022.03.005","article-title":"First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, aptoll: safety and pharmacokinetics in healthy volunteers","volume":"28","author":"Hern\u00e1ndez-Jim\u00e9nez","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib24","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1038\/s41467-021-26463-w","article-title":"A comparative analysis of cell surface targeting aptamers","volume":"12","author":"Kelly","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/nsr\/nwv001","article-title":"Cell-selex-based aptamer-conjugated nanomaterials for cancer diagnosis and therapy","volume":"2","author":"Meng","year":"2015","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.bj.2023.100685_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.omtn.2020.05.025","article-title":"Aptamers against live targets: is in vivo SELEX finally coming to the edge?","volume":"21","author":"Sola","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.bj.2023.100685_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2019.01.045","article-title":"Aptamer-functionalized liposomes for targeted cancer therapy","volume":"448","author":"Moosavian","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bj.2023.100685_bib28","first-page":"1","article-title":"Recent advances in liposome-based targeted cancer therapy","author":"Fidan","year":"2023","journal-title":"J Liposome Res"},{"issue":"6","key":"10.1016\/j.bj.2023.100685_bib29","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1021\/ar500078f","article-title":"Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy","volume":"47","author":"Liang","year":"2014","journal-title":"Acc Chem Res"},{"issue":"5","key":"10.1016\/j.bj.2023.100685_bib30","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/bab.2244","article-title":"SELEX: critical factors and optimization strategies for successful aptamer selection","volume":"69","author":"Kohlberger","year":"2022","journal-title":"Biotechnol Appl Biochem"},{"issue":"20","key":"10.1016\/j.bj.2023.100685_bib31","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.3390\/cancers13205220","article-title":"Selection of a nuclease-resistant RNA aptamer targeting CD19","volume":"13","author":"Esposito","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11033-020-05995-2","article-title":"Generation of BHsAg DNA aptamer using modified cell-based SELEX strategy","volume":"48","author":"Mirian","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.bj.2023.100685_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.124728","article-title":"Selection of DNA aptamer recognizing Cd44 for high-e\ufb03ciency capture of circulating tumor cells","volume":"262","author":"Gao","year":"2023","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/j.bj.2023.100685_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s12195-020-00651-y","article-title":"Crispr-mediated isogenic cell-SELEX approach for generating highly specific aptamers against native membrane proteins","volume":"13","author":"Rosch","year":"2020","journal-title":"Cell Mol Bioeng"},{"key":"10.1016\/j.bj.2023.100685_bib35","series-title":"Aptamers for Analytical Applications","first-page":"1","article-title":"Liu J.Introduction of SELEX and important SELEX variants","author":"Dong","year":"2019"},{"key":"10.1016\/j.bj.2023.100685_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114262","article-title":"Inhibition of cell migration and invasion by ICAM-1 binding DNA aptamers","volume":"628","author":"\u015eener","year":"2021","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bj.2023.100685_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339066","article-title":"A highly specific aptamer probe targeting PD-L1 in tumor tissue sections: mutation favors specificity","volume":"1185","author":"Ren","year":"2021","journal-title":"Anal Chim Acta"},{"issue":"8","key":"10.1016\/j.bj.2023.100685_bib38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acscombsci.9b00059","article-title":"Plasmonic selection of ssDNA aptamers against fibroblast growth factor receptor","volume":"21","author":"Kurt","year":"2019","journal-title":"ACS Comb Sci"},{"issue":"32","key":"10.1016\/j.bj.2023.100685_bib39","doi-asserted-by":"crossref","first-page":"11838","DOI":"10.1073\/pnas.0602615103","article-title":"Aptamers evolved from live cells as effective molecular probes for cancer study","volume":"103","author":"Shangguan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.bj.2023.100685_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000096085","article-title":"DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers","volume":"27","author":"Ferreira","year":"2006","journal-title":"Tumour Biol"},{"issue":"11","key":"10.1016\/j.bj.2023.100685_bib41","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/mt.2014.117","article-title":"Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen","volume":"22","author":"Dassie","year":"2014","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib42","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1038\/s41598-021-87998-y","article-title":"Selection of aptamers against triple negative breast cancer cells using high throughput sequencing","volume":"11","author":"Ferreira","year":"2021","journal-title":"Sci Rep"},{"issue":"16","key":"10.1016\/j.bj.2023.100685_bib43","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.bmcl.2019.06.002","article-title":"In vitro selection of aptamer S1 against MCF-7 human breast cancer cells","volume":"29","author":"Zhang","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bj.2023.100685_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.113109","article-title":"Aptamer-modified M cell targeting liposomes for oral delivery of macromolecules","volume":"222","author":"He","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.bj.2023.100685_bib45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jconrel.2023.03.048","article-title":"Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment","volume":"360","author":"Choi","year":"2023","journal-title":"J Contr Release"},{"key":"10.1016\/j.bj.2023.100685_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.talanta.2018.10.028","article-title":"In vitro selection of DNA aptamers recognizing drug-resistant ovarian cancer by cell-SELEX","volume":"194","author":"He","year":"2019","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20660-3","article-title":"Development and characterization of DNA aptamer against retinoblastoma by cell-SELEX","volume":"12","author":"Maradani","year":"2022","journal-title":"Sci Rep"},{"issue":"25","key":"10.1016\/j.bj.2023.100685_bib48","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1016\/j.biomaterials.2014.04.112","article-title":"Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bj.2023.100685_bib49","first-page":"1228","article-title":"Generation of an aptamer targeting receptor-type tyrosine-protein phosphatase f","volume":"95","author":"Lv","year":"2023","journal-title":"Anal Chem"},{"key":"10.1016\/j.bj.2023.100685_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2022.03.157","article-title":"Identification of DNA aptamers that specifically targets EBV+ nasopharyngeal carcinoma via binding with EphA2\/CD98hc complex","volume":"608","author":"Chen","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bj.2023.100685_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.omtn.2020.02.005","article-title":"Targeting ephrin receptor tyrosine kinase A2 with a selective aptamer for glioblastoma stem cells","volume":"20","author":"Affinito","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.bj.2023.100685_bib52","article-title":"Critical evaluation of aptamer binding for biosensor designs","volume":"146","author":"Zhao","year":"2022","journal-title":"TrAC Trends Anal Chem (Reference Ed)"},{"issue":"5","key":"10.1016\/j.bj.2023.100685_bib53","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1021\/pr801048z","article-title":"Technical and biological issues relevant to cell typing with aptamers","volume":"8","author":"Li","year":"2009","journal-title":"J Proteome Res"},{"issue":"2","key":"10.1016\/j.bj.2023.100685_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/nar\/gkab527","article-title":"Directed evolution of orthogonal RNA\u2013RBP pairs through library-vs-library in vitro selection","volume":"50","author":"Fukunaga","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.bj.2023.100685_bib55","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.3390\/ijms23094890","article-title":"Inhibition of human urokinase-type plasminogen activator (UPA) enzyme activity and receptor binding by DNA aptamers as potential therapeutics through binding to the different forms of UPA","volume":"23","author":"Dreymann","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bj.2023.100685_bib56","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.omtn.2019.11.004","article-title":"Development of a novel DNA oligonucleotide targeting low-density lipoprotein receptor","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"10.1016\/j.bj.2023.100685_bib57","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s12010-022-03834-7","article-title":"Selection and characterization of DNA aptamers targeting hLCN6 protein for sperm capture","volume":"194","author":"Chen","year":"2022","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.bj.2023.100685_bib58","first-page":"10","article-title":"The minimum aptamer publication standards (MAPS guidelines) for de novo aptamer selection","volume":"6","author":"McKeague","year":"2022","journal-title":"Aptamers"},{"issue":"10","key":"10.1016\/j.bj.2023.100685_bib59","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3390\/ijms18102142","article-title":"Recent advances in SELEX technology and aptamer applications in biomedicine","volume":"18","author":"Zhuo","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.bj.2023.100685_bib60","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1073\/pnas.1305804110","article-title":"Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates","volume":"110","author":"Choi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.bj.2023.100685_bib61","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/ijms21072485","article-title":"Antibodies, nanobodies, or aptamers\u2014which is best for deciphering the proteomes of non-model species?","volume":"21","author":"Dhar","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bj.2023.100685_bib62","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/159456","article-title":"Sensitivity and selectivity on aptamer-based assay: the determination of tetracycline residue in bovine milk","volume":"2012","author":"Jeong","year":"2012","journal-title":"Sci World J"},{"issue":"7","key":"10.1016\/j.bj.2023.100685_bib63","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.bj.2023.100685_bib64","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.31635\/ccschem.021.202101337","article-title":"Molecularly engineered aptamers targeting tumor tissue and cancer cells for efficient in vivo recognition and enrichment","volume":"4","author":"Wang","year":"2022","journal-title":"CCS Chem"},{"issue":"35","key":"10.1016\/j.bj.2023.100685_bib65","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1002\/anie.200901452","article-title":"Reversible cell-specific drug delivery with aptamer-functionalized liposomes","volume":"48","author":"Cao","year":"2009","journal-title":"Angew Chem Int Ed"},{"issue":"3","key":"10.1016\/j.bj.2023.100685_bib66","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/nn901374b","article-title":"Aptamer-based tumor-targeted drug delivery for photodynamic therapy","volume":"4","author":"Shieh","year":"2010","journal-title":"ACS Nano"},{"issue":"14\u201315","key":"10.1016\/j.bj.2023.100685_bib67","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.addr.2011.10.002","article-title":"Aptamer-conjugated nanomaterials and their applications","volume":"63","author":"Yang","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.bj.2023.100685_bib68","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3390\/pharmaceutics14122561","article-title":"Aptamers as smart ligands for targeted drug delivery in cancer therapy","volume":"14","author":"Wei","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.bj.2023.100685_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2017.0680","article-title":"Effect of chemical modifications on aptamer stability in serum","volume":"27","author":"Kratschmer","year":"2017","journal-title":"Nucleic Acid Therapeut"},{"issue":"5","key":"10.1016\/j.bj.2023.100685_bib70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/108729002761381276","article-title":"Cellular uptake, distribution, and stability of 10-23 deoxyribozymes","volume":"12","author":"Dass","year":"2002","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"10.1016\/j.bj.2023.100685_bib71","first-page":"166","article-title":"Selection and identification of a novel ssDNA aptamer targeting human skeletal muscle","volume":"20","author":"Sun","year":"2022","journal-title":"Bioact Mater"},{"issue":"27","key":"10.1016\/j.bj.2023.100685_bib72","doi-asserted-by":"crossref","first-page":"15513","DOI":"10.1039\/C9RA00785G","article-title":"In vitro selection of DNA aptamers for the development of chemiluminescence aptasensor for neuron-specific enolase (NSE) detection","volume":"9","author":"Zheng","year":"2019","journal-title":"RSC Adv"},{"issue":"49","key":"10.1016\/j.bj.2023.100685_bib73","doi-asserted-by":"crossref","first-page":"15000","DOI":"10.1021\/acs.langmuir.8b01368","article-title":"DNA oligonucleotide-functionalized liposomes: bioconjugate chemistry, biointerfaces, and applications","volume":"34","author":"Lopez","year":"2018","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/molecules25010003","article-title":"Aptamers chemistry: chemical modifications and conjugation strategies","volume":"25","author":"Odeh","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bj.2023.100685_bib75","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/bc5004313","article-title":"Functionalizing liposomes with anti-CD44 aptamer for selective targeting of cancer cells","volume":"26","author":"Alshaer","year":"2015","journal-title":"Bioconjugate Chem"},{"issue":"9","key":"10.1016\/j.bj.2023.100685_bib76","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/acs.biomac.5b00250","article-title":"Aptamer-modified temperature-sensitive liposomal contrast agent for magnetic resonance imaging","volume":"16","author":"Zhang","year":"2015","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.bj.2023.100685_bib77","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinchem\/37.5.625","article-title":"The biotin-(strept)avidin system: principles and applications in biotechnology","volume":"37","author":"Diamandis","year":"1991","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.bj.2023.100685_bib78","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.ultsonch.2013.12.023","article-title":"Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer","volume":"21","author":"Ninomiya","year":"2014","journal-title":"Ultrason Sonochem"},{"issue":"21","key":"10.1016\/j.bj.2023.100685_bib79","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1039\/D3TB00598D","article-title":"Mucin-targeting-aptamer functionalized liposomes for delivery of cyclosporin a for dry eye diseases","volume":"11","author":"Wong","year":"2023","journal-title":"J Mater Chem B"},{"issue":"59","key":"10.1016\/j.bj.2023.100685_bib80","doi-asserted-by":"crossref","first-page":"36219","DOI":"10.1039\/D0RA07325C","article-title":"Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion","volume":"10","author":"Nsairat","year":"2020","journal-title":"RSC Adv"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib81","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.bj.2023.100685_bib82","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fbioe.2020.00166","article-title":"Recent advances in understanding the protein corona of nanoparticles and in the formulation of \u201cstealthy\u201d nanomaterials","volume":"8","author":"Rampado","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"10.1016\/j.bj.2023.100685_bib83","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.nano.2017.12.003","article-title":"PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure","volume":"14","author":"Mo","year":"2018","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.bj.2023.100685_bib84","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1038\/mtna.2014.21","article-title":"Cell-type-specific, aptamer-functionalized agents for targeted disease therapy","volume":"3","author":"Zhou","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"issue":"28","key":"10.1016\/j.bj.2023.100685_bib85","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1021\/ja504845f","article-title":"Liposomal spherical nucleic acids","volume":"136","author":"Banga","year":"2014","journal-title":"J Am Chem Soc"},{"issue":"19","key":"10.1016\/j.bj.2023.100685_bib86","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1073\/pnas.1305804110","article-title":"Mirkin CA Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates","volume":"110","author":"Choi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"584","key":"10.1016\/j.bj.2023.100685_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3945","article-title":"A first-in-human phase 0 clinical study of RNA interference\u2013based spherical nucleic acids in patients with recurrent glioblastoma","volume":"13","author":"Kumthekar","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40824-023-00365-y","article-title":"Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery","volume":"27","author":"Narwade","year":"2023","journal-title":"Biomater Res"},{"issue":"2","key":"10.1016\/j.bj.2023.100685_bib89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbamem.2015.11.012","article-title":"The protein corona of circulating pegylated liposomes","volume":"1858","author":"Palchetti","year":"2016","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"5","key":"10.1016\/j.bj.2023.100685_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100639","article-title":"Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition, pharmacokinetics, and functionalization","volume":"11","author":"van der Koog","year":"2022","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.bj.2023.100685_bib91","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jconrel.2023.06.012","article-title":"Calcium carbonate nanoparticles tumor delivery for combined chemo-photodynamic therapy: comparison of local and systemic administration","volume":"359","author":"Yakubova","year":"2023","journal-title":"J Contr Release"},{"issue":"1","key":"10.1016\/j.bj.2023.100685_bib92","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12951-023-01826-1","article-title":"Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics","volume":"21","author":"Shi","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.bj.2023.100685_bib93","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.actbio.2021.07.074","article-title":"Spotlight on the protein corona of liposomes","volume":"134","author":"Onishchenko","year":"2021","journal-title":"Acta Biomater"},{"key":"10.1016\/j.bj.2023.100685_bib94","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jconrel.2022.06.039","article-title":"Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression","volume":"343","author":"Kim","year":"2022","journal-title":"J Contr Release"},{"key":"10.1016\/j.bj.2023.100685_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118520","article-title":"Reducing doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: in vitro and in vivo","volume":"262","author":"Ghandhariyoun","year":"2020","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.bj.2023.100685_bib96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/03639045.2022.2095398","article-title":"Pegylated solid lipid nanoparticles functionalized by aptamer for targeted delivery of docetaxel in mice bearing C26 tumor","volume":"48","author":"Shakib","year":"2022","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/j.bj.2023.100685_bib97","doi-asserted-by":"crossref","first-page":"e3116","DOI":"10.1002\/btpr.3116","article-title":"Anti-epithelial cell adhesion molecule RNA aptamer-conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model","volume":"37","author":"Mashreghi","year":"2021","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.bj.2023.100685_bib98","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.2147\/IJN.S272495","article-title":"In vivo targeting of liver cancer with tissue- and nuclei-specific mesoporous silica nanoparticle-based nanocarriers in mice","volume":"15","author":"Ding","year":"2020","journal-title":"Int J Nanomed"},{"issue":"5","key":"10.1016\/j.bj.2023.100685_bib99","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/ph16050751","article-title":"Assessment of aptamer as a potential drug targeted delivery for retinal angiogenesis inhibition","volume":"16","author":"Moreira","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"16","key":"10.1016\/j.bj.2023.100685_bib100","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.3390\/molecules27165089","article-title":"Recent advances in age-related macular degeneration therapies","volume":"27","author":"Fabre","year":"2022","journal-title":"Molecules"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417023001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417023001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T21:40:27Z","timestamp":1724881227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417023001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2319417023001221"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2023.100685","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer-functionalized liposomes for drug delivery","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2023.100685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100685"}}